RTRX - Retrophin Inc (Healthcare: Drug Manufacturers - Major) Projected Earnings Date: 2019-11-04    (Delayed quote data   2025-06-26)
Last
 15.13		 Change
 ⇑ +0.18   (+1.20%)		 Volume
  776,196
Open
 14.99		 High
 15.15		 Low
 14.71
8EMA (Daily)
 14.84		 40EMA (Daily)
 16.06		 50EMA (Daily)
 16.38		 STO (Daily)
 55.739		 MACD Hist (Daily)
 0.316
8EMA (Weekly)
 15.659		 40EMA (Weekly)
 16.43		 50EMA (Weekly)
 16.06		 STO (Weekly)
 21.245		 MACD Hist (Weekly)
 -1.066
Company Profile
Retrophin Inc is a fully integrated biopharmaceutical company focused on the development, acquisition and commercialization of therapies for the treatment of serious, catastrophic or rare diseases.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com